Literature DB >> 25592125

Retained silicone tip of diamond-dusted membrane scraper during vitrectomy in a valved cannula system.

V Felcida1, N Kumar2, R Haynes2, S Habal1, A K Tyagi1.   

Abstract

PURPOSE: To report a complication of retained silicone tip from a diamond-dusted membrane scraper (DDMS) that occurred while using a valved cannula vitrectomy system.
METHOD: Retrospective review of three cases that underwent 23 gauge (G) sutureless vitrectomy for idiopathic macular hole (cases 1 and 2) and myopic macular schisis (case 3).
RESULTS: In all three cases following a standard vitrectomy, the internal limiting membrane (ILM) peeling was initiated by using a 23G DDMS. During the insertion of the DDMS, the flexible silicone tip of the 23G DDMS was detached from the metal shaft and was retained in the 23G valve system and in case 3, the silicone tip got dislodged from the valve onto the retina. Subsequent ILM peeling was completed by using an end-gripping forceps. All underwent intravitreal gas injection at the end. No other complications were noted.
CONCLUSION: These three cases demonstrate an uncommon complication of retained silicone tip within the valved cannula vitrectomy system and this complication should be considered while using flexible instruments in valved cannula systems.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25592125      PMCID: PMC4816365          DOI: 10.1038/eye.2014.325

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  3 in total

1.  Iatrogenic retinal diamond deposits: an unusual complication of using the diamond-dusted membrane scraper.

Authors:  D Gupta; C Goldsmith
Journal:  Eye (Lond)       Date:  2008-10-24       Impact factor: 3.775

2.  The Tano Diamond Dusted Membrane Scraper: indications and contraindications.

Authors:  F Kuhn; V Mester; A Berta
Journal:  Acta Ophthalmol Scand       Date:  1998-12

3.  Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial.

Authors:  Noemi Lois; Jennifer Burr; John Norrie; Luke Vale; Jonathan Cook; Alison McDonald; Charles Boachie; Laura Ternent; Gladys McPherson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.